FC03-05 - An evaluation of service provision by community drug treatment services for opioid dependent pregnant drug users in England and Wales

2011 ◽  
Vol 26 (S2) ◽  
pp. 1826-1826 ◽  
Author(s):  
R. Perez-Montejano ◽  
E. Finch ◽  
K. Wolff
Keyword(s):  
Drug Treatment ◽  
Service Provision ◽  
Drug Users ◽  
Postal Survey ◽  
Chi Square ◽  
Home Office ◽  
England And Wales ◽  
Methadone Dosage ◽  
Treatment Services ◽  
Opioid Users

IntroductionOver the last decade a series of guidelines and recommendations have been published in the UK by the Department of Health, the Home Office, Professional and Non-Professional bodies. However, an optimal strategy and consensus in the management and care of opioid dependent pregnant users has yet to be established.ObjectivesDetermination of existing methods for identifying and managing pregnancy in opioid users prescribed methadone by NHS Treatment Services and regional differences.AimTo survey the management, treatment and follow-up of pregnant opioid users prescribed methadone by Drug Treatment Services in England and Wales.MethodsIn 2006 a POSTAL survey was conducted among 223 Community Drug Treatment Services (CDTS).ResultsSixty-six percent of CDTS responded to the survey (n = 154/233). A Chi-square, Mann_Whitney U Test and/or Kruskal-Wallis analysis revealed significant differences in the composition of CDTS and service provision across regions. Half of CDTS (55.3%) provided a methadone dosage regime lower than that recommended for non-pregnant drug users. There were also significant variations on how professionals approached the management of pregnant opioid users. CDTS with an addiction specialist were significantly more likely (p < .01) to advocate high doses of methadone whereas those with a midwife, obstetrician or social worker involved were more likely (p < .05) to suggest low dose methadone and/or detoxification.ConclusionsService provision for pregnant opioid users is comprehensive but there is still variability in some aspects of the treatment received. The way in which methadone is prescribed is not always optimal. Further work is required in this area.

scholarly journals Controlling Drug Users: Forms of Power and Behavioural Regulation in Drug Treatment Services

2019 ◽  
Author(s):  
Matthew Bacon ◽  
Toby Seddon
Keyword(s):  
Drug Treatment ◽  
Drug Users ◽  
Social Regulation ◽  
Control Techniques ◽  
Treatment Services ◽  
Power And Control ◽  
The Social ◽  
Responsive Regulation ◽  
Drug Problems ◽  
And Control

Abstract This article examines the control practices used in drug treatment services to regulate the behaviour of people with drug problems. Drawing on an extensive qualitative study, we developed a conceptual framework, integrating the notion of responsive regulation with Wrong’s sociology of power. The picture that emerges is of a complex ‘web of controls’, combining diverse forms of power and control techniques, used to steer action and shape behavioural outcomes. It is argued that we can understand these control practices within drug treatment as part of broader strategies for the social regulation of the poor, built on deep-rooted hybrids of punishment and welfare. The article concludes with the suggestion that drug treatment represents an important site for understanding penal power today.

scholarly journals Current patterns of service provision for the psychiatric needs of mentally handicapped people: visiting centres in England and Wales

1990 ◽  
Vol 14 (1) ◽  
pp. 6-7 ◽  
Author(s):  
Gregory O'Brien
Keyword(s):  
Health Authority ◽  
Service Provision ◽  
Working Party ◽  
General Interest ◽  
Mentally Handicapped ◽  
England And Wales ◽  
Treatment Services ◽  
Handicapped People

In 1988, the Cambridge Health Authority commissioned a working party of clinicians and NHS managers to visit a variety of different treatment services which cater for the psychiatric needs of mentally handicapped adults in England and Wales. This survey – part of an ongoing planning exercise – is now complete, new services are being planned in the light of the findings, and the experience may be of general interest to other clinicians and service planners throughout England and Wales.

scholarly journals AVALIAÇÃO DA ADESÃO AO TRATAMENTO MEDICAMENTOSO DE PACIENTES COM DISTÚRBIOS PSIQUIÁTRICOS NO SERVIÇO DE EMERGÊNCIA

2018 ◽  
Vol 9 (4) ◽  
Author(s):  
Maria Carolina Barbosa Teixeira Lopes ◽  
Gabriela Parizzi Bianche ◽  
Andréa Fachini Da Costa ◽  
Meiry Fernanda Pinto Okuno ◽  
Ruth Ester Assayag Batista ◽  
...  
Keyword(s):  
Drug Treatment ◽  
Psychiatric Disorders ◽  
Drug Users ◽  
Sao Paulo ◽  
São Paulo ◽  
Chi Square ◽  
Cross Sectional ◽  
Medicinal Treatment ◽  
High Adherence ◽  
Chi Square Test

Objetivo: Identificar o perfil sociodemográfico e clínico e avaliar a adesão ao tratamento medicamentoso domiciliar e, os fatores associados, de pacientes com distúrbios psiquiátricos atendidos no Serviço de Emergência. Metodologia: Estudo transversal e analítico, realizado no Serviço de Emergência do Hospital São Paulo (HSP), de maio a dezembro de 2015. Foram incluídos 98 adultos com transtorno psiquiátrico agudo ou crônico agudizado. A adesão medicamentosa foi avaliada pelo Teste de Morisky-Green. Para verificar os fatores associados à adesão, utilizou-se o teste Qui-Quadrado (p< 0,05). Resultados: Houve predomínio de homens, adultos, que procuraram o serviço para contenção de comportamento por psicose não orgânica não especificada. Os pacientes com abstinência alcoólica e que não eram usuários de drogas apresentaram maior percentual de alta adesão ao tratamento medicamentoso. Conclusões: A adesão foi baixa e associada ao uso de psicotrópicos e drogas ilícitas.Descritores: Adesão à Medicação; Pacientes; Transtornos Mentais; Serviços Médicos de Emergência; Enfermagem.EVALUATION OF ACCESSION TO THE MEDICINAL TREATMENT OF PATIENTS WITH PSYCHIATRIC DISORDERS IN THE EMERGENCY SERVICEObjective: To identify the socio-demographic and clinical profile and to evaluate the adherence to home drug treatment and, the associated factors, of patients with psychiatric disorders attended at the Emergency Department. Methodology: A cross-sectional and analytical study carried out at the Emergency Service of the São Paulo Hospital (HSP), from May to December, 2015. 98 adults with acute or chronic psychiatric disorders were included. Drug adherence was assessed by the Morisky-Green Test. The chi-square test was used to verify the factors associated with adherence (p <0.05). Results: There was a predominance of men, adults, attending the service to contain behavior by unspecified nonorganic psychosis. Patients with alcohol withdrawal and who were not drug users had a higher percentage of high adherence to drug treatment. Conclusions: Adherence was low and associated with the use of psychotropic drugs and illicit drugs.Descriptors: Medication Adherence; Patients; Mental Disorders; Emergency Medical Services; Nursing.EVALUACIÓN DE LA ADHESIÓN AL TRATAMIENTO MEDICAMENTOSO DE PACIENTES CON DISTURBIOS PSIQUIÁTRICOS EN EL SERVICIO DE EMERGENCIAObjetivo: Identificar el perfil sociodemográfico y clínico y evaluar la adhesión al tratamiento medicamentoso domiciliar y, los factores asociados, de pacientes con disturbios psiquiátricos atendidos en el Servicio de Emergencia. Metodología: Estudio transversal y analítico, realizado en el Servicio de Emergencia del Hospital São Paulo (HSP), de mayo a diciembre de 2015. Se incluyeron 98 adultos con trastorno psiquiátrico agudo o crónico agudizado. La adhesión medicamentosa fue evaluada por la prueba de Morisky-Green. Para verificar los factores asociados a la adhesión se utilizó la prueba Qui-Cuadrado (p <0,05). Resultados: Hubo predominio de hombres, adultos, que buscaban el servicio para contención de comportamiento por psicosis no orgánica no especificada. Los pacientes con abstinencia alcohólica y que no eran usuarios de drogas presentaron mayor porcentaje de alta adhesión al tratamiento medicamentoso. Conclusiones: La adhesión fue baja y asociada al uso de psicotrópicos y drogas ilícitas.Descriptores: Cumplimiento de la Medicación; Pacientes, Trastornos Mentales; Servicios Médicos de Urgencia; Enfermería.

Screening for hepatitis B and vaccination of injecting drug users in NHS drug treatment services

Addiction ◽  
1990 ◽  
Vol 85 (12) ◽  
pp. 1657-1659 ◽  
Author(s):  
MICHAEL FARRELL ◽  
MALCOLM BATTERSBY ◽  
JOHN STRANG
Keyword(s):  
Hepatitis B ◽  
Drug Treatment ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Treatment Services

scholarly journals THU0454 SOMATIC SYMPTOMS IN FIBROMYALGIA AND THEIR CORRELATION WITH DRUG TREATMENT

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 464.2-464
Author(s):  
M. Antivalle ◽  
M. Agosti ◽  
A. Batticciotto ◽  
S. Costi ◽  
V. Giorgi ◽  
...  
Keyword(s):  
Drug Treatment ◽  
Drug Users ◽  
Somatic Symptoms ◽  
Dry Mouth ◽  
Appetite Loss ◽  
Blurred Vision ◽  
Chi Square ◽  
Dry Eyes ◽  
Few Data ◽  
Sun Sensitivity

Background:Drug treatment in fibromyalgia (FM) is often disappointingly ineffective, and there are currently very few data to support therapeutic choices towards a personalized medicine approach.Objectives:To evaluate the prevalence of selected somatic symptoms in FM, and to study their relationship with drug treatments.Methods:The study population consisted of 526 patients (471 F 55 M, mean age 47.31±11.33 yrs) affected by FM not associated with other rheumatic diseases. All patients were required to compile a questionnaire reporting the presence of 42 somatic symptoms -as suggested (1) – in the last 7 days. Drug usage was assessed by interview.Results:On average, patients reported the presence of 17.04±6.68 symptoms (range 4-35), with ample variations in the prevalence of different symptoms (Fig. 1), ranging from over 95% (fatigue and muscle pain) to less than 10 %, seizures being reported by only 2 patients (0.4%). 31.1% of patients were not taking any drug for their FM. The most frequently used drugs were analgesics (ANA, 41.7%) followed by benzodiazepines (BD, 29.1%), SSRIs (16%), gabapentinoids (GABA, 14,4%), and NSRI (14.3%) (Fig. 2). Different drugs were associated with a different spectrum of somatic symptoms: as compared to non users, BD users reported a significantly higher (p< 0.05 by chi-square test) prevalence of irritable bowel (65.4% vs 52.3%), fatigue (98.7% vs 94.9%), thinking difficulties (78.4% vs 68.5%), muscle weakness (94.1% vs 81.7%), abdominal pain (55.6% vs 43.9%), insomnia (73.9% vs 56.6%), depression (63.4 % vs 37.2%), constipation (60.1% vs 42.9%), pain in upper abdomen (50.3% vs 40.2%), nausea (53.6% vs 38.3%), nervousness (71.9% vs 61.5%), chest pain (49.0 vs 37.75), blurred vision (65.4% vs 53.6%), dry mouth (72.5% vs 52.3%), itching (56.2% vs 44.5%), vomiting (13.7% vs 7.8%), taste change (22.2% vs 12.7%), dry eyes (55.6% vs 41.0%), breath shortness (56.9% vs 47.7%), appetite loss (33.3% vs 19.7%), painful urination (15.0% vs 8.4%), and bladder spasms (18.3% vs 8.6%). NRSI users reported a significantly higher prevalence of thinking difficulties, constipation, blurred vision, dry mouth, wheezing, dry eyes, easy bruising. Among GABA users, there was a higher prevalence of thinking difficulties, numbness, insomnia, constipation, nausea, dry mouth, dry eyes, appetite loss, sun sensitivity, easy bruising, and bladder spasms. In no cases a higher prevalence of symptoms was recorded in drug non users vs users.Conclusion:The usage of different drugs in FM is associated with different somatic symptoms. The higher prevalence of symptoms in drug users as compared to non users raises serious questions concerning the opportunity or the appropriateness of drug selection in FM.References:[1]Wolfe F., et al. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10Disclosure of Interests: :None declared

Sign in / Sign up

Export Citation Format

Share Document